Table 3.

Hemodynamics assessment (mmHg)

	LVSP	+ dp/dt	−dp/dt	LVEDP
C	126.03 ± 4.56	603.85 ± 6.59	623.03 ± 8.59	10.03 ± 0.91
D	103.26 ± 4.08 a	513.86 ± 10.06 a	430.48 ± 27.37 a	17.65 ± 1.74 a
DA	103.96 ± 3.85 a	514.01 ± 8.86 a	430.98 ± 25.58 a	16.98 ± 1.55 a
DMA	102.83 ± 5.02 a	510.43 ± 9.45 a	396.78 ± 28.12 a	17.02 ± 1.02 a

C control, D diabetes, DA diabetes + adiponectin, DMA diabetes + miR-711 inhibitor + adiponectin, LVSP left ventricular systolic pressure, + dp/dt, the maximum rate of increase in left ventricular pressure, −dp/dt, the maximum rate of decrease in left ventricular pressure, LVEDP left ventricular end-diastolic pressure

^aP < 0.05, compared with the C group